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Background: Clarithromycin (CLM) is a semi-synthetic macrolide antibiotic with a broad antibacterial spectrum. It
has a potent activity against Myc. Pneumonia, Legionella Spp., H. Influenza, and Mor. Catarrhalis. It is also used for
prevention and treatment of disseminated M. Avium infections in patients with AIDS. The therapeutic importance
and wide use of CLM promotes the growing interest in developing proper methods for its determination in bulk
and pharmaceutical formulations.
Results: The present study describes the development and validation of a novel assay that can increase the
throughput and reduce the consumption of organic solvents in the charge transfer (CT)-based spectrophotometric
determination of CLM. In this assay, the CT reaction between CLM as n-electron donor and 2,3-dichloro-5,6-dicyano-1,
4-benzoquinone (DDQ) as a π-electron acceptor was performed in the 96-microwells of an assay plate. The color signals
of the CT complex were measured at 450 nm by microwell-plate absorbance reader. The linear range of the assay was
20−850 μg mL−1. The limits of detection and quantitation were 15.5 and 51.2 μg mL−1, respectively. The proposed assay
gave very high precisions; the relative standard deviation (RSD) values did not exceed 1.82%.
Conclusions: The assay described herein has a high throughput property that facilitates the processing of large
number of samples in a reasonable time. As well, it consumes minimum volumes of organic solvents, thus it
significantly reduces the exposures of the analysts to the toxic effects of organic solvents, and reduce the analysis cost
by 50-folds. The results demonstrated that the proposed assay has great practical value in the routine analysis of CLM
in quality control laboratories.
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Clarithromycin (CLM), 6-O-methylerythromycin (Figure 1)
is a semi-synthetic macrolide antibiotic with a broad
antibacterial spectrum. It has a potent activity against
Myc. Pneumonia, Legionella Spp., H. Influenza, and
Mor. Catarrhalis [1,2]. It is also used for prevention
and treatment of disseminated M. Avium infections
in patients with AIDS [1]. CLM interferes with RNA
dependent bacterial protein synthesis, resulting in a
bateriostatic effect on pathogens [2].
The therapeutic importance of CLM was behind the
growing interest in the development of analytical
methods for its determination in raw material, pharma-
ceutical formulations and/or biological fluids. A litera-
ture survey revealed that most of the reported methods
for determination of CLM are HPLC with electrochem-
ical [3,4] or mass spectrometric detector [5-7]. These
methods were devoted to the determination of CLM in
biological fluids and employed sophisticated and expen-
sive instrumentation that are mostly not available in
pharmaceutical quality control laboratories. Therefore,
the applications of these methods for determination of
CLM in pharmaceutical formulations are limited.
Spectrophotometry is the most widely used technique in
pharmaceutical analysis because of its inherent simplicity
and wide availability in most quality control laboratories
[8]. CLM molecule lacks a suitable chromophore that
enables its determination in the pharmaceutical formula-
tions based on the direct measurement of its UV absorp-
tion. Therefore, derivatization of CLM was necessary for
its spectrophotometric determination. Unfortunately, most
the spectrophotometric methods reported for the determin-
ation of CLM in its pharmaceutical formulations [8-17]
were associated with some major drawbacks. These draw-
backs included tedious liquid-liquid extraction procedures
using large volumes of organic solvents in the methodsFigure 1 The chemical structure of clarithromycin (CLM).based on formation of extractive ion-pair associates [11-15],
and the employment of multiple-steps and long time for
completing the whole procedure [16,17]. Therefore, the de-
velopment of a new alternative spectrophotometric method
for determination of CLM in its pharmaceutical formula-
tions is very essential.
The charge-transfer (CT) reactions are widely employed
in the development of simple and convenient spectrophoto-
metric methods for many pharmaceutical compounds
[18-23]. Few CT-based spectrophotometric methods have
been described for determination of CLM [24,25]. These
methods employed the conventional non-automated tech-
nique and consequently their throughput is low, and their
applications in pharmaceutical quality control laboratories
are limited. Moreover, these methods consumed large vol-
umes of organic solvents, which leads to high analysis cost,
and more importantly, the incidence of exposure of the an-
alysts to the toxic effects of the organic solvents [26-30]
such as neurotoxic symptoms [26], increased risk of
some reproductive outcomes among women [27], increased
risk of spontaneous abortion among pregnant women
[28,29], and increased risk of lymphohaemalopoietic cancer
(leukemia and lymphomas) in both men and women [30].
Reduction of human exposure to organic solvents is one of
the main objectives of hygienists, public authorities, World
Health Organization, environment protection agencies, and
occupational safety and health administrations. For these
reasons, investigating new alternative methodology to re-
duce the consumption of organic solvents in CT-based
spectrophotometric analysis of CLM is very important.
The present study describes the development and val-
idation of a novel CT-based spectrophotometric assay
for determination of CLM in pharmaceutical formula-
tions. In this assay, the reaction was carried out in
96-microwell assay plates and the color signals were
measured by microwell-plate reader. The assay described
herein offered three major advantages: (1) providing a
high throughput analytical methodology that can facili-
tate the processing of large number of samples in a rela-
tively short time, (2) reduction in the exposures of the
analysts to the toxic effects of organic solvents, thus it
leads to reduction in the analysis cost by 50-folds.
Experimental
Apparatus
Microwell-plate absorbance reader (ELx 808, Bio-Tek In-
struments Inc. Winooski, USA) was used for all the mea-
surements in 96-microwell plates. UV-1601 PC (Shimadzu,
Kyoto, Japan) ultraviolet-visible spectrophotometer with
matched 1 cm quartz cells was used for recording the ab-
sorption spectra. 96−Microwell plates were a product of
Corning/Costar Inc. (Cambridge, USA). Finnpipette adjust-
able 8−channel-pipette was obtained from Sigma Chemical
Co. (St. Louis, MO, USA).
Figure 2 Absorption spectrum of reaction product of CLM (100
μg mL−1) with DDQ (1 mg mL−1).
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Secondary standard clarithromycin (CLM) was obtained
from Riyadh Pharma Industries (Riyadh, Saudi Arabia);
purity was 99.96%. DDQ (Merck, Germany) was 1 mg/mL
in methanol and it was prepared fresh daily. Klaricid® tab-
lets (Abbot Industries, Italy) labeled to contain 250 mg
CLM were obtained from the local market.
Preparation of standard solutions
Into a 10-mL calibrated flask, 20 mg of CLM was accur-
ately weighed, dissolved in 5 mL methanol, and com-
pleted to volume with the same solvent. This stock
solution was diluted with methanol to obtain the suit-
able concentrations in the linear range of the assay.
Preparation of tablet sample solutions
Twenty tablets were weighed and finely powdered. A
quantity of the powder equivalent to 20 mg of CLM was
transferred into a 10-mL calibrated flask, dissolved in 5
mL methanol, swirled and sonicated for 5 min, com-
pleted to volume with the methanol, shaken well for 15
min, and filtered. The first portion of the filtrate was
rejected, and a measured volume of the filtrate was di-
luted quantitatively with methanol to yield the suitable
concentrations in the linear range of the assay.
General analytical procedure
Accurately measured aliquots (100 μL) of the standard
or sample solution of varying concentrations of CLM
(40–1700 μg mL−1) were transferred into wells of 96-
microwell assay plates. One hundred microliters of DDQ
solution (1 mg/mL) was added, and the reaction was
allowed to proceed at room temperature (25 ± 1°C) for 5
min. The absorbances of the resulting solutions were
measured at 450 nm by the microwell-plate reader.
Blank wells were treated similarly except 100 μL of
methanol was used instead of sample, and the absor-
bances of the blank wells were subtracted from those of
the other wells.
Determination of molar ratio
The Job’s method of continuous variation [31] was
employed. Master equimolar solutions (2×10─3 M) of
each of CLM and DDQ were prepared. Series of 200 μL
portions of the master solutions of CLM with DDQ were
made up comprising different complementary ratios
(0:10, 1:9, ……, 9:1, 10:0, inclusive) in each well of the
assay plate. The reaction was allowed to proceed at
room temperature (25 ± 1°C) for 5 min. The absor-
bances of the developed colors were measured at 450
nm by the microwell-plate reader against blank wells
treated similarly except methanol was used instead of
CLM sample. The measured absorbances were plotted
as a function of CLM mole fraction. The generatedplot was used for determination the molar ration of
CLM:DDQ.
Results and discussion
Strategy for assay development
CLM was selected for this study based on its thera-
peutic importance and the urgent need for a new
spectrophotometric methodology that can overcome
the major drawback of the existing methods for its
determination. The structure of the CLM contains a
macrocyclic lactone and a neutral sugar moiety at-
tached to the lactone (Figure 1). Another important
structural characteristic is the presence of other sugar
moiety containing a dimethylamine group, which con-
fers to the CLM molecule a basic behavior and makes
CLM a potential n-electron donating substances [32].
Based on this fact, CT reaction with electron acceptor
was considered in this study.
Previous studies for the CT reactions of polyhalo-/
polycyanoquinones electron acceptors revealed that DDQ
was one of the most reactive reagents, as its CT reaction
proceeds rapidly, and yielded high sensitive assays when
compared with other polyhaloquinones [23]. For these
reasons, DDQ was selected as electron acceptor in the
development of the assay described herein.
The following sections describe the establishment of the
optimization factors that influence the chemical reaction
and the analytical performance of the proposed assay.
Absorption spectral characteristics
The interaction of CLM with DDQ was allowed to
proceed at room temperature, and the absorption
spectrum of the produced chromogen was recorded.
CLM gave red colored chromogen showing absorption
maximum at 450 nm (Figure 2). This band was attrib-
uted to the formation of the radical anion DDQ- [33],
Figure 3 Effect of DDQ concentration on its reaction with CLM.
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original donor-acceptor (D-A) complex:
Dþ A⇌ D‐Að Þ⇌
Polar
solvent Dþ þ A‐
complex radical ions
Further support of this assignment was provided by
the absorption maxima with those of DDQ radical anion
produced by the iodide reduction assay [33]. The dis-
sociation of the (D-A) complex was promoted by the
high ionizing power of the polar solvent and the result-
ing peaks in the absorption spectra of CLM-DDQ reac-
tion mixtures were similar to the maxima of the radical
anions of the acceptors obtained by the iodide reduction
assay [33].
Optimization of experimental conditions
The optimization of experimental conditions affecting
the reaction in the 96-well format was investigated by al-
tering each reaction variable in a turn while keeping the
others constant. In all cases, measurements were carried
out at 450 nm by a microwell plate reader.
Effect of solvent
The first factor evaluated in this study was the solvent
employed. The solvent plays an important role in CT
reactions, since it must be able to facilitate the total
CT and then allow the complex dissociation and
stabilization of the radical anion formed, which is the
absorbing molecule. Previous study [23] demonstrated
that solvents with high dielectric constant are more ef-
fective to execute this task. Taking this fact into account,
the reaction was tested in different solvents (methanol,
ethanol, propanol, butanol, acetone, and acetonitrile).
Although the highest dielectric constant of acetonitrile;
however, the best sensitivity was achieved when metha-
nol was used. This was probably attributed to the ability
of methanol to form stable hydrogen bonds with the
radical anion. Therefore, methanol was used in all fur-
ther experiments.
Effect of DDQ concentration
In the chemical derivatization-based spectrophotometric
analysis, the maximum conversion of the analyte into
absorbing specie depends on the amount of the reagent
available in the reaction solution and the equilibrium in-
volved. The effect of DDQ concentration on its reaction
with CLM was studied using 100 μL of varying DDQ
concentrations (0−4 mg mL−1) and 100 μL of a fixed
concentration of CLM (650 μg mL−1). The final concen-
trations DDQ and CLM in each reaction well were 0−2
mg mL−1 and 325 μg mL−1, respectively. The results
(Figure 3) indicated that 100 μL of 1 mg mL−1 was theoptimum DDQ concentration, as this concentration gave
the highest absorbances. We selected this higher con-
centration for carrying out the reaction for two reasons:
(1) to offer enough DDQ concentration for reaction with
high concentrations of CLM, when any, in the routine
practical application, and (2) higher DDQ concentration
offers, in accordance, high precise readings. As shown in
Figure 3, when the DDQ molar concentration was simi-
lar to that of the CLM concentration there was a total
consumption of CLM, indicating that one mole of CLM
reacts with one mole of DDQ reagent.
Effect of time and temperature
The optimum reaction time was determined by monitor-
ing the color development in the microwells at room
temperature (25 ± 1°C). Complete color development
was attained instantaneously, however for higher preci-
sion readings, the reaction was allowed to proceed for 5
min. Higher temperatures (40−60°C) had no significant
effect on the reaction, thus all investigations were car-
ried out at room temperature. The developed color
remained stable at room temperature for at least a fur-
ther 30 min.
A summary for the optimum conditions is given in
Table 1.
Molar ratio and mechanism of the reaction
Job’s method of continuous variation [31] was used for
determining the molar ratio of CLM to DDQ. From the
obtained Job’s plot, it was concluded that the CLM:DDQ
ratio is 1:1 (Figure 4). This indicated that one mole of
DDQ interacted with one mole of CLM and confirmed
the assumption rose before when the effect of DDQ
concentration was studied (Figure 3). Considering the
presence of one nitrogen atoms in CLM structure
(dimethylamine group in the sugar moiety), the reaction
was postulated to proceed as shown in Figure 5. One
Table 1 Optimum conditions for the charge-transfer reac-
tion of CLM with DDQ
Condition Studied range Optimum
DDQ conc. (mg mL−1) 0 − 4 1
Solvent Differenta Methanol
Reaction time (min) 0 − 30 5
Temperature (°C) 25 − 60 25
λmax (nm) 400 − 600 450
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Figure 5 Mechanism of CT reaction of CLM with DDQ.
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charge-deficient center of DDQ molecule.
Validation of the proposed assay
Calibration, range, and sensitivity
Under the above mentioned optimum reaction condi-
tions, the calibration curve for the analysis of CLM by
the proposed assay was constructed by plotting the ab-
sorbances as a function of the corresponding CLM con-
centrations. The regression equation for the results was
derived using the least-squares method Beer’s law plot
(11-points) was linear in the range of 20–850 μg mL−1.
The calibration equation was: A = 0.0073 + 0.0018 C
(r = 0.9985), where A, C and r are the absorbance, con-
centration of CLM and correlation coefficient, respect-
ively. The limits of detection (LOD) and quantitation
(LOQ) were determined [34]. The following formula was
used: LOD or LOQ= ×SDa/b, where × = 3.3 for LOD
and 10 for LOQ, SDa is the standard deviation of the
intercept, and b is the slope. The LOD and LOQ were
found to be 15.5 and 51.2 μg mL−1, respectively. The
quantitative parameters of the proposed assay are given
in Table 2.
Accuracy and precision
Accuracy of the proposed assay was assessed by analyt-
ical recovery studies. Recovery was determined by theFigure 4 Job's plot for CT reaction of CLM with DDQ.standard addition method. Known amounts of CLM
were added to pre-determined drug-containing pharma-
ceutical formulation, and then determined by the pro-
posed assay; 3 replicates were used in each experiment.
The analytical recovery was calculated and found to be
97.3−101.5 ± 0.25−1.54%. This range is acceptable
according to the guidelines for validation of analyticalTable 2 Quantitative parameters for the analysis of CLM
by the proposed assay
Parameter Value




LOD ( μg mL−1) 15.5
LOQ ( μg mL−1) 51.2
Table 4 Analysis of CLM in the presence of common
excipients by the proposed assay
Excipient Recovery (% ± SD)a
Starch (50)b 97.9 ± 1.54
Microcrystalline cellulose (10) 100.2 ± 0.25
Silica gel (10) 98.5 ± 1.34
Talc (10) 97.4 ± 0.89
Titanium oxide (10) 101.3 ± 1.02
Magnesium stearate (10) 97.2 ± 1.54
Average ± SD 98.8 ± 1.65
aValues are mean of three determinations.
bFigures in parenthesis are the amounts in mg added per 50 mg of CLM.
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posed assay.
The precisions of the proposed assay were determined
on samples of drug solutions at three concentration
levels for each drug (Table 3) by analyzing 5 replicates of
each sample as a batch in a single assay run. The relative
standard deviations (RSD = standard deviation/mean;
expressed as percentage) did not exceed 1.82% (Table 3)
proving high precision of the assay for the routine appli-
cation in quality control laboratories. This high level of
precision was attributed to the accuracy of the volumes
that have been concomitantly dispensed in the micro-
wells by multi-channel pipettes, and completeness of the
reaction in a small volume (200 μL).
Selectivity
The selectivity of the proposed methodology was
assessed by studying the possible interferent species on
the reaction of CLM with DDQ. Samples were prepared
by mixing known amount (50 mg) of CLM with various
amounts of the common excipients (starch, microcrys-
talline cellulose, silica gel, talc, titanium dioxide, and
magnesium stearate) were tested. The results (Table 4)
revealed that no interference was observed from any of
these excipients with the proposed methodology as the
average recovery value was 98.8 ± 1.65%. The absence of
interference from these excipients was attributed to the
extraction of CLM from the samples by methanol which
does not dissolve these excipients.
The ability of the proposed method to detect intact
CLM in presence of its degradation products and/or re-
lated substances, if any, was not studied in the method-
ology described herein. This was attributed to the
common inherent disability of most CT-based spectro-
photometric method, rather than the separation-based
methods, to act as stability-indicating methods.
Robustness and ruggedness
Robustness was examined by evaluating the influence of
small variation in the method variables on its analytical
performance. In these experiments, one parameter was
changed whereas the others were kept unchanged, and
the recovery percentage was calculated each time. It was
found that small variation in the method variables did





Within-assay, n = 5 Between-assays, n = 5
50 1.25 1.82
250 0.98 1.05
500 1.34 1.65were 98.59 – 102.18 ± 0.58 – 1.24%. This indicated the
reliability of the proposed methodology during its rou-
tine application for the analysis of CLM.
Ruggedness was also tested by applying the proposed
methodology to the assay of CLM using the same oper-
ational conditions but using two different instruments at
two different laboratories and different elapsed time. Re-
sults obtained from lab-to-lab and day-to-day variations
were reproducible, as the relative standard deviations
(RSD) did not exceed 2%.
Application of the proposed assay
The commercially available pharmaceutical formulations
of CLM (Klaricid® tablets) were subjected to the analysis
by the proposed and validated methods [10] and the ob-
tained results were then statistically compared with each
other. The mean percentage recovery, relative to the la-
beled amounts, obtained by the proposed methodology
was 99.5 ± 1.81 (Table 5). In the t- and F-tests, no sig-
nificant differences were found between the calculated
and theoretical values of both the proposed and the re-
ported assays at 95% confidence level. This indicated
similar accuracy and precision in the analysis by the pro-
posed and reported methods.
Conclusions
The present study described the development and valid-
ation of a novel assay for the CT-based spectrophoto-
metric determination of CLM. In this assay, the reaction
was carried out in 96-microwell plates and the color sig-
nals were measured by microwell-plate reader. The assayTable 5 Analysis of CLM in tablets by the proposed and
reported methods





Klaricid® tablets 99.5 ± 1.81 99.35 ± 1.12 0.62 2.61
aValues are mean of five determinations ± SD.
bThe tabulated values at 95% confidence limit are 2.78 and 6.39, respectively.
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ation of analytical procedures and the results were satis-
factory. The applicability of the proposed methodology
for the quality control of CLM was confirmed as indi-
cated by the acceptable recovery values. The assay
described herein has the following advantages:
– Providing a high throughput analysis that enables
the processing of large number of samples in a short
time. This property was attributed to the use of
multi-channel pipettes for efficient dispensing the
solutions, carrying out the analytical reaction in
96-well plates (as reaction vessels), and measuring
the color signals in the 96 wells at ~ 30 seconds by
the plate reader.
– Reducing the consumption of organic solvents in the
CT-based spectrophotometric analysis of CLM, ac-
cordingly reduction in the exposures of the analysts
to the toxic effects of organic solvents.
– Reduction in the analysis cost by 50-folds (200 μL in
the present methodology versus 10,000 μL in the
reported conventional CT-based spectrophotometric
methods [24,25]) which can be reflected on the price
for the finished dosage forms, thus it can reduce the
expenses for the medications to the patients.
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